1-20 of 322 results for subject:Tuberculosis
Librarians' tools
- Search time
- 0.258 seconds
- Solr query time
- 0.008 seconds
- Search query
- subject:Tuberculosis
- We searched for
- subject_t:Tuberculosis OR subject_t:TB OR subject_ses:13401
Type
House
Session
Year
Department
Member
More
Primary member
More
Answering member
More
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health and Social Care, what funding provisions his Department has made in relation to the forthcoming National Tuberculosis Action Plan 2026–2031.
To ask the Secretary of State for Health and Social Care, what funding provisions his Department has made in relation to the forthcoming National Tuberculosis Action Plan 2026–2031.
The Government is currently developing the Tuberculosis National Action Plan for 2026 to 2031. The content of the plan, including any associated funding requirements, has not yet been finalised. Any proposals with financial implications will be subject to the usual cross‑Government processes, including agreement with HM Treasury. Details, with funding commitments, will be included when the plan is published.
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what amount of UK ODA is projected to be allocated to tuberculosis (a) prevention and (b) treatment in Malawi in each of the next three financial years.
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what amount of UK ODA is projected to be allocated to tuberculosis (a) prevention and (b) treatment in Malawi in each of the next three financial years.
I am pleased to confirm the UK will pledge £850 million to the Global Fund's Eighth Replenishment 2026-2028. This investment is expected to help save up to 1.3 million lives and avert up to 22 million new cases of HIV, TB, and malaria globally, delivering up to £13 billion in economic returns. The Global Fund allocation to Malawi will be determined following the conclusion of the replenishment.
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, how much official development assistance funding was allocated for tuberculosis (a) prevention and (b) treatment in Malawi in each financial year since 2015-16.
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, how much official development assistance funding was allocated for tuberculosis (a) prevention and (b) treatment in Malawi in each financial year since 2015-16.
In November 2022, the UK pledged £1 billion to the 7th replenishment of the Global Fund to Fight AIDS, Tuberculosis and Malaria, which will help to provide tuberculosis (TB) treatment and care for 98,000 people, screen 1.8 million people for TB and provide 3,700 people with treatment for multidrug-resistant TB. Previous UK contributions to the Global Fund were £800 million during 2014-16, £1.2 billion during 2017-19, and £1.4 billion during 2020-22.
The UK contribution to the Global Fund is not earmarked by country or disease, so the requested breakdown is not available. However, the Global Fund allocation to Malawi was US$450 million in 2017-19 (including $9 million for TB), $513 million during 2020-22 (including $20 million for TB) and a pledged total of $517 million for 2023-25 (including $20 million for TB).
My Noble Friend the Minister of State for International Development and Africa (The Rt Hon Baroness Chapman of Darlington) has today made the following statement:
I wish to update the House on the Government’s decision on investment in the Eighth Replenishment of the Global Fund to Fight AIDS, Tuberculosis and...
My Noble Friend the Minister of State for International Development and Africa (The Rt Hon Baroness Chapman of Darlington) has today made the following statement:
I wish to update the House on the Government’s decision on investment in the Eighth Replenishment of the Global Fund to Fight AIDS, Tuberculosis and...
I wish to update the House on the Government’s decision on investment in the Eighth Replenishment of the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) which covers 2026-28.
Diseases like HIV, TB and malaria are not only preventable and treatable, they also disproportionately affect the poorest and...
I wish to update the House on the Government’s decision on investment in the Eighth Replenishment of the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) which covers 2026-28.
Diseases like HIV, TB and malaria are not only preventable and treatable, they also disproportionately affect the poorest and...
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the availability of tuberculosis medication on the provision of healthcare in London.
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the availability of tuberculosis medication on the provision of healthcare in London.
Medicine supply chains are complex, global, and highly regulated, and there are a number of reasons why supply can be disrupted, many of which are not specific to the United Kingdom and are outside of Government control, including manufacturing difficulties, access to raw materials, sudden demand spikes or distribution issues, and regulatory issues. There are approximately 14,000 licensed medicines and the overwhelming majority are in good supply. Where there are supply issues, these are managed at a national level across the UK rather than at a regional level.
NHS England has been notified of some issues with medicines used to treat tuberculosis (TB), however there is sufficient stock available from alternative suppliers to meet normal demand for most of them. The products facing current disruptions include Voractiv tablets until late June 2025, and rifampicin 150 milligram capsules until mid-August 2025, both due to manufacturing delays. Comprehensive management plans were communicated to healthcare professionals on 1 June 2025, highlighting issues with TB medicines and advising of the actions to take during this time.
NHS England is actively working with the affected suppliers to address these supply issues as quickly as possible to ensure that UK patients have access to the medications they need.
The team are working intensively to improve the availability of TB medicines, which includes co-ordinating with the British Thoracic Society to ensure centres treating active TB have access to available supplies, and directing trusts to build buffer stocks of unlicensed imports of TB medicines whilst there is a supply issue with some UK licensed products. The team are also supporting the impacted supplier and trusts to ensure that the available TB medicine supplies are equitably distributed and allocated fairly across the UK. The team is continuing to explore medium to long term solutions to the supply issues, working with those mentioned as well as the Medicines and Healthcare products Regulatory Agency and clinicians within the NHS.
To ask the Secretary of State for Health and Social Care, what estimate he has made of the cost to the NHS of treating patients who have contracted tuberculosis in each of the last five years.
To ask the Secretary of State for Health and Social Care, what estimate he has made of the cost to the NHS of treating patients who have contracted tuberculosis in each of the last five years.
This information is not held centrally. NHS England captures and publishes aggregated costs, namely the average unit cost of providing defined services to NHS patients in England, and patient-level costs/PLICS, a cost based on the specific interactions a patient has, and the events related to their healthcare activity, which are available at the following link:
https://www.england.nhs.uk/costing-in-the-nhs/national-cost-collection/
This provides cost information about patients who have been admitted to a hospital for treatment with a primary diagnosis of tuberculosis, rather than patients who have contracted tuberculosis in the last five years.
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, whether he has made an assessment of the potential impact of proposed reductions to Official Development Assistance on tuberculosis (a) screening, (b) diagnosis and (c) treatment.
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, whether he has made an assessment of the potential impact of proposed reductions to Official Development Assistance on tuberculosis (a) screening, (b) diagnosis and (c) treatment.
Decisions on how the Official Development Assistance (ODA) budget will be used are being worked through as part of the ongoing Spending Review, based on various factors including impact assessments.
We plan to publish final 2025/26 ODA programme allocations in the FCDO Annual Report & Accounts this summer.
The UK has played a significant role with international counterparts to tackle tuberculosis (TB) in recent decades.
Since 2002, Tuberculosis deaths have been reduced by 36 per cent in countries where the Global Fund invests. The UK is a leading donor to the Global Fund and will this year co-host the 8th replenishment of the Global Fund together with South Africa.
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve tuberculosis (a) screening, (b) diagnosis and (c) treatment services for (i) people experiencing homelessness and (ii) asylum seekers.
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve tuberculosis (a) screening, (b) diagnosis and (c) treatment services for (i) people experiencing homelessness and (ii) asylum seekers.
The Department works collaboratively with Government departments, local authorities, and third-sector organisations to overcome barriers to healthcare access for people seeking asylum and those experiencing homelessness, ensuring they can access and receive necessary care.
The UK Health Security Agency (UKHSA) collects and publishes data on tuberculosis (TB). The UKHSA and NHS England’s joint TB Action Plan for England 2021 to 2026 outlines outcomes and indicators to achieve a 90% reduction in people with TB by 2035, which is aligned with the World Health Organization’s elimination targets.
There are specific actions within the collaborative UKHSA and NHS England TB Action Plan 2021 to 2026 to strengthen the prevention and detection of active disease in groups at higher risk of TB, such as those experiencing homelessness and seeking asylum, through targeted screening and active engagement with local authorities, their public health teams, and the third sector.
To ask the Deputy Foreign Secretary, what steps his Department is taking with its international partners to help ensure that people living with tuberculosis have access to healthcare.
To ask the Deputy Foreign Secretary, what steps his Department is taking with its international partners to help ensure that people living with tuberculosis have access to healthcare.
The UK is a leading donor to the fight against tuberculosis. Our £1 billion replenishment of the Global Fund to Fight AIDS, Tuberculosis and Malaria will provide TB treatment and care to more than one million people between 2023 and 2025. We are a leading funder of TB research, including through the TB Alliance and also invest in improving access and affordability for key TB products and testing innovative approaches to providing TB services. These investments contribute to achieving the commitments made in the TB High Level 2023 political declaration, including supporting people to have access to appropriate healthcare.
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what assessment he has made of of the impact of the humanitarian crisis in Gaza on the delivery of HIV and TB services.
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what assessment he has made of of the impact of the humanitarian crisis in Gaza on the delivery of HIV and TB services.
We have no means of independently assessing the impact of the crisis on medical services however we are aware of World Health Organisation (WHO) reporting on the significant impact the crisis is having on the delivery of medical services and wider aid. The UK continuously assesses needs as part of our humanitarian response in Gaza and there is an urgent requirement for the entry of significantly more aid. At this stage, we are focused on getting more aid through the Rafah crossing and other land routes, which is the most effective way of getting humanitarian support in at scale. We are also urging Israel to open other border crossings, such as Kerem Shalom, to enable more humanitarian aid to reach civilians in need. This is still not enough to meet the immediate needs of the population and we support pauses in hostilities to improve access to humanitarian assistance for all people in need.
Motion that this House has considered UN high-level meetings in 2023. Agreed to on question.
Motion that this House has considered UN high-level meetings in 2023. Agreed to on question.
I beg to move,
That this House has considered UN high-level meetings in 2023.
It is an honour to serve under your chairmanship, Mr Twigg. Most of, if not all, the pressing global challenges we face today are not confined to a single continent or country. We have all seen that—including recently...
I beg to move,
That this House has considered UN high-level meetings in 2023.
It is an honour to serve under your chairmanship, Mr Twigg. Most of, if not all, the pressing global challenges we face today are not confined to a single continent or country. We have all seen that—including recently...
I congratulate my hon. Friend on securing this important debate. Does he agree with the director of Liverpool School of Tropical Medicine, Professor David Lalloo, who has said:
“As academics, public and global health experts and healthcare professionals, we see the close interrelationship between tuberculosis, pandemic preparedness and response, and universal...
I congratulate my hon. Friend on securing this important debate. Does he agree with the director of Liverpool School of Tropical Medicine, Professor David Lalloo, who has said:
“As academics, public and global health experts and healthcare professionals, we see the close interrelationship between tuberculosis, pandemic preparedness and response, and universal...
I thank my right hon. Friend for his important intervention. I agree and will cover those points later in my talk, but I want to put that aside for now. Yes, it is internationally known and accepted that this is an opportunity that every state should take on board.
Those ambitious...
I thank my right hon. Friend for his important intervention. I agree and will cover those points later in my talk, but I want to put that aside for now. Yes, it is internationally known and accepted that this is an opportunity that every state should take on board.
Those ambitious...
It is a pleasure to serve under your chairship, Mr Twigg. I thank the hon. Member for Ealing, Southall (Mr Sharma) for securing this important debate. It is very well timed, as Ministers are agreeing the statements that will go forward to the three high-level meetings on universal health coverage,...
It is a pleasure to serve under your chairship, Mr Twigg. I thank the hon. Member for Ealing, Southall (Mr Sharma) for securing this important debate. It is very well timed, as Ministers are agreeing the statements that will go forward to the three high-level meetings on universal health coverage,...
It is a pleasure to serve under your chairship, Mr Twigg. I thank my hon. Friend the Member for Ealing, Southall (Mr Sharma) for securing this important debate on the upcoming UN high-level meetings on tuberculosis, pandemic preparedness and response, and universal health coverage.
The year 2023 marks the halfway point...
It is a pleasure to serve under your chairship, Mr Twigg. I thank my hon. Friend the Member for Ealing, Southall (Mr Sharma) for securing this important debate on the upcoming UN high-level meetings on tuberculosis, pandemic preparedness and response, and universal health coverage.
The year 2023 marks the halfway point...
It is a pleasure to serve under your chairmanship, Mr Twigg. I warmly congratulate the hon. Member for Ealing, Southall (Mr Sharma) on securing the debate. I recognise his long-standing commitment to international development issues, universal healthcare and global justice, demonstrated in today’s debate, in his co-chairmanship of the all-party...
It is a pleasure to serve under your chairmanship, Mr Twigg. I warmly congratulate the hon. Member for Ealing, Southall (Mr Sharma) on securing the debate. I recognise his long-standing commitment to international development issues, universal healthcare and global justice, demonstrated in today’s debate, in his co-chairmanship of the all-party...
There has been a consensus in this debate that resources need to be directed at trying to prevent pandemics and get rid of as many diseases as we can. One of the proposals to be considered at the high-level talks is transferring some decision making—the declaration of pandemics, for instance—from...
There has been a consensus in this debate that resources need to be directed at trying to prevent pandemics and get rid of as many diseases as we can. One of the proposals to be considered at the high-level talks is transferring some decision making—the declaration of pandemics, for instance—from...
With the greatest respect to the hon. Member, I think that that is a point more usefully directed at the Minister, because it is the Government who represent the United Kingdom at the World Health Organisation. I am a believer in popular sovereignty; I would like Scotland to be an...
With the greatest respect to the hon. Member, I think that that is a point more usefully directed at the Minister, because it is the Government who represent the United Kingdom at the World Health Organisation. I am a believer in popular sovereignty; I would like Scotland to be an...